# Jemincare clinical trials: 37 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 37 trials with Jemincare as lead sponsor, 18 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Jemincare: 37 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/jemincare

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 37
- Recruiting or not yet: 18
- Read on: November 19, 2026

## Trials

The 25 newest of 37, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 2, 2026 | NCT07909070 | A Study to Investigate the Pharmacokinetics of JMKX003142 in Healthy Participants and Participants With Hepatic Impairment | Jemincare | Phase 1 | Not yet recruiting | ADPKD (Autosomal Dominant Polycystic Kidney Disease), Renal Edema | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909070) |
| September 30, 2026 | NCT07848945 | Phase I Study of JY1001 Injection | Jemincare | Phase 1 | Not yet recruiting | Pain After Surgery | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07848945) |
| September 25, 2026 | NCT07841093 | A Study of JMKX003142 Tablet to Treat Renal Edema | Jemincare | Phase 3 | Not yet recruiting | Renal Edema, Nephrogenic Edema | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07841093) |
| May 4, 2026 | NCT07565441 | Drug-Drug Interactions of JMKX003142 in Healthy Participants | Jemincare | Phase 1 | Not yet recruiting | ADPKD (Autosomal Dominant Polycystic Kidney Disease) | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07565441) |
| April 7, 2026 | NCT07513857 | Trial of JYB1904 Injection in Adolescent Participants | Jemincare | Phase 1 | Not yet recruiting | Allergic Diseases | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07513857) |
| March 13, 2026 | NCT07470177 | A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults | Jemincare | Phase 1 | Not yet recruiting | ADPKD (Autosomal Dominant Polycystic Kidney Disease) | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07470177) |
| March 10, 2026 | NCT07463053 | Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers | Jemincare | Phase 1 | Not yet recruiting | ADPKD (Autosomal Dominant Polycystic Kidney Disease) | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07463053) |
| March 9, 2026 | NCT07459452 | Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis | Jemincare | Phase 2 | Not yet recruiting | Perennial Allergic Rhinitis | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07459452) |
| February 11, 2026 | NCT07402213 | Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria. | Jemincare | Phase 3 | Recruiting | Chronic Spontaneous Urticaria | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07402213) |
| November 21, 2025 | NCT07242274 | Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC | Jemincare | Phase 3 | Not yet recruiting | NSCLC (Non-small Cell Lung Cancer) | 472 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07242274) |
| October 6, 2025 | NCT07208136 | A Study of JMKX005425 in Patients With MSI-H/dMMR Advanced Solid Tumors | Jemincare | Phase 1 | Recruiting | Advanced Solid Tumors | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07208136) |
| September 18, 2025 | NCT07181265 | Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects | Jemincare | Phase 1 | Not yet recruiting | Autosomal Dominant Polycystic Kidney Disease (ADPKD) | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07181265) |
| April 29, 2025 | NCT06949020 | A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema | Jemincare | Phase 2 | Completed | Cardiac Edema | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06949020) |
| April 27, 2025 | NCT06946927 | A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation | Jemincare | Phase 1 | Recruiting | NSCLC (Advanced Non-small Cell Lung Cancer) | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06946927) |
| March 18, 2025 | NCT06880848 | Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China | Jemincare | Phase 4 | Completed | Carcinoma, Basal Cell (BCC) | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06880848) |
| February 18, 2025 | NCT06832657 | Study of JMKX003948 Ophthalmic Suspension in Healthy Participants | Jemincare | Phase 1 | Not yet recruiting | Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06832657) |
| January 30, 2025 | NCT06800651 | Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Jemincare | Phase 2 | Recruiting | ADPKD (Autosomal Dominant Polycystic Kidney Disease) | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06800651) |
| December 18, 2024 | NCT06740019 | A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion | Jemincare | Phase 1 | Recruiting | Malignant Pleural Effusions (Mpe) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06740019) |
| November 1, 2024 | NCT06670534 | A Dose-finding Study of JMKX003142 in Treatment of Renal Edema | Jemincare | Phase 2 | Completed | Edema Secondary, Edema Leg | 133 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06670534) |
| October 29, 2024 | NCT06664125 | Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia | Jemincare | Phase 2 | Unknown | Hyperphosphatemia | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06664125) |
| October 26, 2024 | NCT06658964 | Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects | Jemincare | Phase 1 | Unknown | ADPKD (autosomal Dominant Polycystic Kidney Disease) | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06658964) |
| August 12, 2024 | NCT06549309 | Trial of JMKX003801 in Healthy Participants | Jemincare | Phase 1 | Unknown | Healthy | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06549309) |
| July 19, 2024 | NCT06509334 | Trial of JYB1904 in Chronic Spontaneous Urticaria. | Jemincare | Phase 2 | Recruiting | Chronic Spontaneous Urticaria | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06509334) |
| June 25, 2024 | NCT06473948 | To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects | Jemincare | Phase 1 | Unknown | Solid Tumor, Adult | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06473948) |
| June 3, 2024 | NCT06438757 | Trial of JYB1904 in Patients With Allergic Asthma | Jemincare | Phase 2 | Completed | Allergic Asthma | 69 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06438757) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 23 |
| Phase 2 | 9 |
| Phase 3 | 3 |
| Phase 4 | 2 |

## By status

| Status | Trials |
| --- | --- |
| Unknown | 13 |
| Not yet recruiting | 11 |
| Recruiting | 7 |
| Completed | 6 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Polycystic Kidney, Autosomal Dominant | 7 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Chronic Urticaria | 2 |
| Pleural Effusion, Malignant | 2 |
| Renal Insufficiency, Chronic | 1 |
| Glomerulonephritis | 1 |
| Rhinitis, Allergic, Perennial | 1 |
| Carcinoma | 1 |
| Carcinoma, Basal Cell | 1 |
| Edema | 1 |
| Macular Degeneration | 1 |
| Hyperphosphatemia | 1 |
| Myeloproliferative Disorder, Chronic, with Eosinophilia | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Edema, Cardiac | 1 |
| Heart Failure | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Mills in the United States](https://specstream.ai/data/businesses/mills/united-states)
- [Masonry and concrete contractors in the United States](https://specstream.ai/data/businesses/masonry-and-concrete-contractors/united-states)
- [Laser cutting companies in the United States](https://specstream.ai/data/businesses/laser-cutting-companies/united-states)
- [IP and internet law firms in the United States](https://specstream.ai/data/businesses/ip-and-internet-law-firms/united-states)
- [Hydraulic repair companies in the United States](https://specstream.ai/data/businesses/hydraulic-repair-companies/united-states)
- [Hepatology practices in the United States](https://specstream.ai/data/businesses/hepatology-practices/united-states)
